The possible role of genetic testing in the early identification of patients at increased risk of developing anthracycline-induced cardiotoxicity
Event:
ESC Congress 2020
Topic:
Cardiotoxicity of Drugs and Other Therapies
Session:
Chronic Heart Failure ePosters
